Journal of Lipid Research · 2017 · 35 citations · 51 references
Life SciencesBiochemistryNutritional SciencesInflammationInnate ImmunityLipid BiochemistryCardiovascular DiseaseCoronary Artery DiseaseInflammatory SignalingLipid MetabolismLipoprotein MetabolismMetabolic InflammationAtherosclerosis Molecular MechanismsAtherosclerotic Lipid AccumulationDietary Fat EffectsDietary Fatty AcidsInflammation In Cardiovascular DiseaseLipid AccumulationLipid Atherosclerosis LinkUnfolded Protein Response
Elevated plasma levels of LDL-cholesterol are widely accepted to accelerate the development of atherosclerosis. Besides LDL, elevated plasma triglycerides are increasingly recognized as a risk factor for coronary artery disease. More specifically, recent human genetic studies have pointed toward a causal role of hypertriglyceridemia in atherosclerosis development. Accordingly, strategies aimed at reducing hypertriglyceridemia in humans offer a promising therapeutic approach to lower the risk of coronary artery disease. Triglycerides are present in the blood as part of chylomicrons and very low density lipoproteins, and are hydrolyzed by the enzyme, LPL (1). Hence, enhanced hydrolysis of triglycerides by LPL attenuates hypertriglyceridemia and may be targeted to retard the development of coronary artery disease (2).
51